Investigating how COVID-19 affects pituitary gland function
Mechanisms for post-COVID pituitary damage
This study is looking into how COVID-19 might affect the pituitary gland and cause long-lasting fatigue in people, even if they only had mild symptoms, to help improve care for those dealing with these issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10683355 on NIH RePORTER |
What this research studies
This research explores the potential damage to the pituitary gland caused by COVID-19, particularly in patients who may have experienced mild symptoms. It aims to understand the mechanisms behind post-COVID chronic fatigue syndrome, which affects a significant number of survivors. By examining the presence of the SARS-CoV-2 virus in the pituitary gland and its impact on hormone production, the study seeks to establish better healthcare strategies for those suffering from these complications. The research involves analyzing blood samples and postmortem tissues to identify changes in pituitary function.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults who have recovered from COVID-19 and are experiencing symptoms of chronic fatigue or hormonal imbalances.
Not a fit: Patients who have not had COVID-19 or do not exhibit symptoms related to pituitary dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients experiencing post-COVID fatigue and related hormonal issues.
How similar studies have performed: Previous research has indicated that viral infections can lead to endocrine dysfunction, suggesting that this investigation could yield valuable insights into post-COVID health issues.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Araki, Takako — University of Minnesota
- Study coordinator: Araki, Takako
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.